Cargando…

Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry

BACKGROUND: The burden of frequent respiratory exacerbations in COPD patients with mild-to-moderate spirometric impairment and smokers with preserved lung function is unknown. METHODS: We categorized COPD participants in COPDGene with post-bronchodilator FEV1%predicted≥50% by the annual exacerbation...

Descripción completa

Detalles Bibliográficos
Autores principales: Fortis, Spyridon, Wan, Emily S., Kunisaki, Ken, Eyck, Patrick Tel, Ballas, Zuhair K., Bowler, Russell P., Crapo, James D., Hokanson, John E., Wendt, Chris, Silverman, Edwin K., Comellas, Alejandro P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333066/
https://www.ncbi.nlm.nih.gov/pubmed/35911870
http://dx.doi.org/10.1016/j.yrmex.2020.100025
_version_ 1784758800575627264
author Fortis, Spyridon
Wan, Emily S.
Kunisaki, Ken
Eyck, Patrick Tel
Ballas, Zuhair K.
Bowler, Russell P.
Crapo, James D.
Hokanson, John E.
Wendt, Chris
Silverman, Edwin K.
Comellas, Alejandro P.
author_facet Fortis, Spyridon
Wan, Emily S.
Kunisaki, Ken
Eyck, Patrick Tel
Ballas, Zuhair K.
Bowler, Russell P.
Crapo, James D.
Hokanson, John E.
Wendt, Chris
Silverman, Edwin K.
Comellas, Alejandro P.
author_sort Fortis, Spyridon
collection PubMed
description BACKGROUND: The burden of frequent respiratory exacerbations in COPD patients with mild-to-moderate spirometric impairment and smokers with preserved lung function is unknown. METHODS: We categorized COPD participants in COPDGene with post-bronchodilator FEV1%predicted≥50% by the annual exacerbation frequency into three groups: i)frequent exacerbators (top 5%; n = 109), ii)exacerbators (>0 but less than frequent exacerbators; n = 1,009), and iii)No exacerbation (n = 981). Exacerbations were defined as respiratory episodes requiring antibiotics and/or systemic steroids. We performed a Cox proportional hazards regression analysis to examine the association with mortality. We repeated the same process in current/former smokers with preserved spirometry (FEV1≥80%predicted and FEV1/FVC≥0.7). RESULTS: Among 2,099 COPD participants, frequent exacerbators had ≥1.8 exacerbations/year and were responsible for 34.3% of the total exacerbations. There were 102 (10.4%) deaths in the group with no exacerbations, 119 (11.8%) in the exacerbator group, and 24 (22%) in the frequent exacerbators. Adjusted mortality in frequent exacerbators was higher relative to individuals with no exacerbations (hazard ratio (HR) = 1.98; 95%CI = 1.25–3.13). An increase in frequency of exacerbations by one exacerbation/year was associated with increased mortality (HR = 1.40,95%CI = 1.21–1.62). Among 3,143 participants with preserved spirometry, frequent exacerbators had ≥0.8 exacerbations/year and were responsible for more than half of the exacerbations. There were 93 (4.2%) deaths in the group with no exacerbations, 28 (3.8%) in the exacerbator group, and 14 (7.6%) in the frequent exacerbators. The adjusted mortality was increased in frequent exacerbators with preserved spirometry relative to those with no exacerbations (HR = 2.25; 95%CI = 1.26–4.01). CONCLUSIONS: In COPD participants with mild-to-moderate spirometric impairment and smokers with preserved spirometry, the frequent exacerbator phenotype is responsible for a large proportion of total exacerbations and associated with high mortality.
format Online
Article
Text
id pubmed-9333066
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-93330662022-07-28 Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry Fortis, Spyridon Wan, Emily S. Kunisaki, Ken Eyck, Patrick Tel Ballas, Zuhair K. Bowler, Russell P. Crapo, James D. Hokanson, John E. Wendt, Chris Silverman, Edwin K. Comellas, Alejandro P. Respir Med X Article BACKGROUND: The burden of frequent respiratory exacerbations in COPD patients with mild-to-moderate spirometric impairment and smokers with preserved lung function is unknown. METHODS: We categorized COPD participants in COPDGene with post-bronchodilator FEV1%predicted≥50% by the annual exacerbation frequency into three groups: i)frequent exacerbators (top 5%; n = 109), ii)exacerbators (>0 but less than frequent exacerbators; n = 1,009), and iii)No exacerbation (n = 981). Exacerbations were defined as respiratory episodes requiring antibiotics and/or systemic steroids. We performed a Cox proportional hazards regression analysis to examine the association with mortality. We repeated the same process in current/former smokers with preserved spirometry (FEV1≥80%predicted and FEV1/FVC≥0.7). RESULTS: Among 2,099 COPD participants, frequent exacerbators had ≥1.8 exacerbations/year and were responsible for 34.3% of the total exacerbations. There were 102 (10.4%) deaths in the group with no exacerbations, 119 (11.8%) in the exacerbator group, and 24 (22%) in the frequent exacerbators. Adjusted mortality in frequent exacerbators was higher relative to individuals with no exacerbations (hazard ratio (HR) = 1.98; 95%CI = 1.25–3.13). An increase in frequency of exacerbations by one exacerbation/year was associated with increased mortality (HR = 1.40,95%CI = 1.21–1.62). Among 3,143 participants with preserved spirometry, frequent exacerbators had ≥0.8 exacerbations/year and were responsible for more than half of the exacerbations. There were 93 (4.2%) deaths in the group with no exacerbations, 28 (3.8%) in the exacerbator group, and 14 (7.6%) in the frequent exacerbators. The adjusted mortality was increased in frequent exacerbators with preserved spirometry relative to those with no exacerbations (HR = 2.25; 95%CI = 1.26–4.01). CONCLUSIONS: In COPD participants with mild-to-moderate spirometric impairment and smokers with preserved spirometry, the frequent exacerbator phenotype is responsible for a large proportion of total exacerbations and associated with high mortality. 2021-11 2020-12-29 /pmc/articles/PMC9333066/ /pubmed/35911870 http://dx.doi.org/10.1016/j.yrmex.2020.100025 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Article
Fortis, Spyridon
Wan, Emily S.
Kunisaki, Ken
Eyck, Patrick Tel
Ballas, Zuhair K.
Bowler, Russell P.
Crapo, James D.
Hokanson, John E.
Wendt, Chris
Silverman, Edwin K.
Comellas, Alejandro P.
Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry
title Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry
title_full Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry
title_fullStr Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry
title_full_unstemmed Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry
title_short Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry
title_sort increased mortality associated with frequent exacerbations in copd patients with mild-to-moderate lung function impairment, and smokers with normal spirometry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333066/
https://www.ncbi.nlm.nih.gov/pubmed/35911870
http://dx.doi.org/10.1016/j.yrmex.2020.100025
work_keys_str_mv AT fortisspyridon increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry
AT wanemilys increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry
AT kunisakiken increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry
AT eyckpatricktel increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry
AT ballaszuhairk increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry
AT bowlerrussellp increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry
AT crapojamesd increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry
AT hokansonjohne increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry
AT wendtchris increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry
AT silvermanedwink increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry
AT comellasalejandrop increasedmortalityassociatedwithfrequentexacerbationsincopdpatientswithmildtomoderatelungfunctionimpairmentandsmokerswithnormalspirometry